BridgeBio Pharma, Inc. is a pharmaceutical company dedicated to identifying, advancing, and providing medical solutions for various genetic conditions.
52W Range
62ndpctl
Volume
0.61×avg
Market Cap
15.00BUSD
P/E Ratio
-21.4TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
BridgeBio Pharma, Inc.
BBIONASDAQ Global Select·USD·Closed
BridgeBio Pharma, Inc.
BBIONASDAQ·USD·Closed
$76.60
−2.64%
$76.60
−$2.08 (2.64%)
52W Range
62ndpctl
Volume
0.61×avg
Mkt Cap
15.00BUSD
P/E
-21.4TTM
Div Yield
–ann
BBIO: BridgeBio Pharma, Inc. Stock Analysis | finqOS
